OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
MEDL57

Medi Lifestyle Ltd

Healthcare Facilities & ServicesVerified

Medi Lifestyle Ltd exhibits a highly leveraged capital structure, with total liabilities of MYR 6,325,710 and total equity of MYR -5,479,950, resulting in a negative debt-to-equity ratio of -0.22. The company's liquidity position is weak, as indicated by a current ratio of 0.13, suggesting significant short-term financial stress. The negative net income of MYR -3,857,590 and operating income of MYR -3,753,620 further underscore the company's financial instability. Profitability metrics are severely underperforming relative to industry norms. The company's return on equity (ROE) of 0.7039 is negative in absolute terms due to the negative equity base, and its return on assets (ROA) of -4.5611 indicates a loss-making operation. These figures are far below the typical performance of companies in the Healthcare Facilities & Services industry, which usually exhibit positive ROE and ROA values. The negative gross profit of MYR -54,020 and operating cash flow of MYR -3,976,600 further highlight the company's inability to generate sustainable earnings. The company's revenue is distributed across four segments: Healthcare, Outsourced Services, Commodity Trading, and Corporate. However, the financial data does not provide a breakdown of revenue by segment, making it difficult to assess the contribution of each segment to the company's overall performance. The geographic exposure is primarily in Southeast Asia, particularly in the Commodity Trading segment, which focuses on palm oil derivatives in Indonesia. The lack of detailed segmental and geographic revenue data limits the ability to evaluate the company's diversification and risk exposure. The company's growth trajectory is concerning, with no clear indication of improvement in the current fiscal year. The negative operating income and net income suggest a continuation of losses, and there is no evidence of a turnaround in the near term. The capital expenditure of MYR -3,850 indicates minimal investment in growth initiatives, which is inconsistent with the typical behavior of companies aiming to expand or improve operational efficiency. The absence of positive revenue growth or margin improvement signals a lack of momentum in the business. The risk assessment highlights significant liquidity and solvency risks. The company's liquidity is rated as medium, but the negative net cash position after subtracting total debt indicates a high risk of insolvency. The dilution risk is currently low, but the negative equity position and high debt levels could lead to future dilution if the company needs to raise additional capital. The risk assessment also notes that the company's financial structure is highly leveraged, which increases its vulnerability to economic downturns and interest rate fluctuations. Recent events and filings do not provide specific details on the company's strategic initiatives or financial restructuring plans. The lack of recent positive developments or significant capital injections suggests that the company may be struggling to attract investor confidence. The absence of detailed information on recent events or management actions further complicates the assessment of the company's future prospects.

30-day price · MEDL+0.01 (+27.6%)
Low$0.03High$0.06Close$0.04As of17 May, 00:00 UTC
Profile
CompanyMedi Lifestyle Ltd
TickerMEDL.SI
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
AI analysis

Business. Medi Lifestyle Ltd operates as an investment holding company with primary activities in healthcare services, outsourced services, and commodity trading, generating revenue through postpartum care, chiropractic and physiotherapy services, and palm oil derivatives trading.

Classification. Medi Lifestyle Ltd is classified under the Healthcare sector, specifically in the Healthcare Services & Equipment business sector, with a confidence level of 0.92.

Medi Lifestyle Ltd exhibits a highly leveraged capital structure, with total liabilities of MYR 6,325,710 and total equity of MYR -5,479,950, resulting in a negative debt-to-equity ratio of -0.22. The company's liquidity position is weak, as indicated by a current ratio of 0.13, suggesting significant short-term financial stress. The negative net income of MYR -3,857,590 and operating income of MYR -3,753,620 further underscore the company's financial instability. Profitability metrics are severely underperforming relative to industry norms. The company's return on equity (ROE) of 0.7039 is negative in absolute terms due to the negative equity base, and its return on assets (ROA) of -4.5611 indicates a loss-making operation. These figures are far below the typical performance of companies in the Healthcare Facilities & Services industry, which usually exhibit positive ROE and ROA values. The negative gross profit of MYR -54,020 and operating cash flow of MYR -3,976,600 further highlight the company's inability to generate sustainable earnings. The company's revenue is distributed across four segments: Healthcare, Outsourced Services, Commodity Trading, and Corporate. However, the financial data does not provide a breakdown of revenue by segment, making it difficult to assess the contribution of each segment to the company's overall performance. The geographic exposure is primarily in Southeast Asia, particularly in the Commodity Trading segment, which focuses on palm oil derivatives in Indonesia. The lack of detailed segmental and geographic revenue data limits the ability to evaluate the company's diversification and risk exposure. The company's growth trajectory is concerning, with no clear indication of improvement in the current fiscal year. The negative operating income and net income suggest a continuation of losses, and there is no evidence of a turnaround in the near term. The capital expenditure of MYR -3,850 indicates minimal investment in growth initiatives, which is inconsistent with the typical behavior of companies aiming to expand or improve operational efficiency. The absence of positive revenue growth or margin improvement signals a lack of momentum in the business. The risk assessment highlights significant liquidity and solvency risks. The company's liquidity is rated as medium, but the negative net cash position after subtracting total debt indicates a high risk of insolvency. The dilution risk is currently low, but the negative equity position and high debt levels could lead to future dilution if the company needs to raise additional capital. The risk assessment also notes that the company's financial structure is highly leveraged, which increases its vulnerability to economic downturns and interest rate fluctuations. Recent events and filings do not provide specific details on the company's strategic initiatives or financial restructuring plans. The lack of recent positive developments or significant capital injections suggests that the company may be struggling to attract investor confidence. The absence of detailed information on recent events or management actions further complicates the assessment of the company's future prospects.
Key takeaways
  • Medi Lifestyle Ltd is operating at a significant loss, with negative net income and operating income.
  • The company's capital structure is highly leveraged, with a negative debt-to-equity ratio and weak liquidity.
  • Profitability metrics are severely underperforming, with negative ROE and ROA.
  • The company's growth trajectory is uncertain, with no clear signs of improvement in the current fiscal year.
  • The risk assessment indicates significant liquidity and solvency risks, with a high probability of insolvency.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyMYR
Revenue$4.4M
Gross profit-$54.0k
Operating income-$3.8M
Net income-$3.9M
R&D
SG&A
D&A
SBC
Operating cash flow-$4.0M
CapEx-$3.9k
Free cash flow-$3.8M
Total assets$845.8k
Total liabilities$6.3M
Total equity-$5.5M
Cash & equivalents
Long-term debt$1.2M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book-$5.5M
Net cash-$1.2M
Current ratio0.1
Debt/Equity-0.2
ROA-4.6%
ROE70.4%
Cash conversion1.0%
CapEx/Revenue-0.1%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Biotechnology · cohort 9 companies
MetricMEDLActivity
Op margin-84.9%11.5% medp25 9.9% · p75 15.0%bottom quartile
Net margin-87.3%8.6% medp25 6.3% · p75 12.4%bottom quartile
Gross margin-1.2%28.8% medp25 28.8% · p75 28.8%bottom quartile
CapEx / revenue-0.1%4.2% medp25 3.8% · p75 4.2%bottom quartile
Debt / equity-22.0%71.3% medp25 60.7% · p75 71.3%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-05 03:17 UTC#c528a7dc
Source: analysis-pipeline (hybrid)Generated: 2026-05-05 03:19 UTCJob: 7234f3ce